£16.14
On Hold
Arbidol antiviral 10 caps x 100 mg
More than 10 available
Details
Shipping: United Kingdom: free (more destinations)
Condition: Brand new
*The store has not been updated recently. You may want to contact the merchant to confirm the availability of the product.
ARBIDOL antiviral 10 capsules x 100 mg.
Active substance: Umifenovir
Antiviral agent. It has an immunomodulatory and anti-influenza effect. Specifically suppresses influenza a and B viruses (Influenzavirus A, B), including highly pathogenic subtypes a (H1N1)pdm09 and A (H5N1), as well as other viruses that cause acute respiratory viral infections (ARVI) (coronavirus associated with severe acute respiratory syndrome (SARS), rhinovirus (Rhinovirus), adenovirus (Adenovirus), respiratory syncytial virus (Pneumovirus) and the parainfluenza virus (Paramyxovirus)). According to the mechanism of antiviral action, it belongs to fusion inhibitors (fusions), interacts with the virus's hemagglutinin and prevents the fusion of the virus's lipid envelope and cell membranes. It has a moderate immunomodulatory effect, increases the body's resistance to viral infections.
Indications for use:
Prevention and treatment of adults and children:
- influenza A and B, SARS, severe acute respiratory syndrome (SARS) (including those complicated by bronchitis, pneumonia),
- secondary immunodeficiency States,
- complex therapy of chronic bronchitis, pneumonia and recurrent herpetic infection.
Dosage: Taking the drag begins with the appearance of the first symptoms of flu and other SARS, preferably no later than 3 days from the beginning of the disease.
Children from 6 to 12 years - 100 mg, children over 12 years and adults-200 mg 4 times/day (every 6 hours) for 5 days.
Prevention: During an epidemic of influenza and other SARS: children from 6 to 12 years-100 mg, children over 12 years and adults-200 mg 2 times a week for 3 weeks.
In direct contact with patients with influenza and other ARVI-children 6 to 12 years-100 mg, children older than 12 years and adults-200 mg 1 time/day for 10-14 days.
Active substance: Umifenovir
Antiviral agent. It has an immunomodulatory and anti-influenza effect. Specifically suppresses influenza a and B viruses (Influenzavirus A, B), including highly pathogenic subtypes a (H1N1)pdm09 and A (H5N1), as well as other viruses that cause acute respiratory viral infections (ARVI) (coronavirus associated with severe acute respiratory syndrome (SARS), rhinovirus (Rhinovirus), adenovirus (Adenovirus), respiratory syncytial virus (Pneumovirus) and the parainfluenza virus (Paramyxovirus)). According to the mechanism of antiviral action, it belongs to fusion inhibitors (fusions), interacts with the virus's hemagglutinin and prevents the fusion of the virus's lipid envelope and cell membranes. It has a moderate immunomodulatory effect, increases the body's resistance to viral infections.
Indications for use:
Prevention and treatment of adults and children:
- influenza A and B, SARS, severe acute respiratory syndrome (SARS) (including those complicated by bronchitis, pneumonia),
- secondary immunodeficiency States,
- complex therapy of chronic bronchitis, pneumonia and recurrent herpetic infection.
Dosage: Taking the drag begins with the appearance of the first symptoms of flu and other SARS, preferably no later than 3 days from the beginning of the disease.
Children from 6 to 12 years - 100 mg, children over 12 years and adults-200 mg 4 times/day (every 6 hours) for 5 days.
Prevention: During an epidemic of influenza and other SARS: children from 6 to 12 years-100 mg, children over 12 years and adults-200 mg 2 times a week for 3 weeks.
In direct contact with patients with influenza and other ARVI-children 6 to 12 years-100 mg, children older than 12 years and adults-200 mg 1 time/day for 10-14 days.
RU, NSO
